Table 1 Baseline demographic, lung function and quality of life data
LTOT(n = 72)NIV+LTOT(n = 72)
Age (years)68.8 (67.1 to 70.5)67.2 (65.3 to 69.1)
Gender (% male)61%69%
BMI (kg/m2)25.4 (24.0 to 26.8)25.5 (24.3 to 26.7)
FEV1.0 (litres)0.55 (0.51 to 0.59)0.63 (0.57 to 0.69)
FEV1.0 (% predicted)23.1 (21.4 to 24.8)25 (22.4 to 27.6)
FVC (litres)1.76 (1.60 to 1.92)1.98 (1.80 to 2.16)
FVC (% predicted)54.8 (51.0 to 58.6)57.5 (53.9 to 61.1)
FEV1.0/FVC (%)32.9 (30.9 to 34.9)32.9 (30.3 to 35.5)
Tlco (ml/min/mmHg)6.76 (5.96 to 7.56)8.61 (7.49 to 9.73)
Tlco (% predicted)30.7 (27.9 to 33.5)37.2 (33.2 to 41.2)
Oxygen treatment (h/day)20.5 (19.5 to 21.5)20 (18.8 to 21.2)
Pao2 (mm Hg, air)52.5 (50.1 to 54.9) (n = 62)54.8 (52.4 to 57.2) (n = 61)
Paco2 (mm Hg, air)54.4 (52.6 to 56.2) (n = 62)52.6 (51.0 to 54.2) (n = 61)
SGRQ64.1 (49.9–70.8)*69 (57.2–77.2)*
  • Values are mean (95% CI) or *median (interquartile range).

  • BMI, body mass index; FEV1.0, forced expiratory volume in 1 s; FVC, forced vital capacity; LTOT, long-term oxygen therapy; NIV + LTOT, nocturnal non-invasive ventilation plus long-term oxygen therapy; Pao2, Paco2, arterial oxygen and carbon dioxide tensions; SGRQ, St George Respiratory Questionnaire; Tlco, single breath lung transfer factor for carbon monoxide.